๐ฆ๐๐๐๐ฎ๐ถ๐ป๐ฎ๐ฏ๐น๐ฒ, ๐น๐ผ๐ป๐ด-๐๐ฒ๐ฟ๐บ ๐ฟ๐ฒ๐น๐ฎ๐๐ถ๐ผ๐ป๐๐ต๐ถ๐ฝ๐ ๐๐ถ๐๐ต ๐ผ๐๐ฟ ๐๐๐ฎ๐ธ๐ฒ๐ต๐ผ๐น๐ฑ๐ฒ๐ฟ๐ ๐ฏ๐ฒ๐ด๐ถ๐ป ๐๐ถ๐๐ต ๐๐ฟ๐๐๐.
Our Business Values define the way we conduct business responsibly across our organization. Building on our 2024 risk mapping analysis, weโve developed targeted mitigation measures tailored to each site and function, aligned with our goal to achieve ISO 37001 certification for our anti-corruption management system.
๐ Training is the cornerstone of our integrity culture. In 2025, 93% of at-risk office-based employees in France, Germany, China and India, completed ethics training, and 57% of production site-based employees took part in whistleblowing training. We target 100% in 2026.
๐ Our whistleblowing procedure provides a secure channel for employees and relevant third parties across the value chain to report suspected violations or misconduct. 13 whistleblowing reports were received in 2025.
๐ป Information security is a key priority. 90% of at-risk employees completed information security training in 2025. Beyond this, we maintain a strong culture of vigilance, with regular updates on emerging threats and recommended actions to keep awareness high. In 2025, we signed the Sustainable IT Charter, reinforcing our commitment to a responsible and sustainable approach to digital infrastructure.
To find out more about our governance framework, training programs and sustainable IT, check out our ๐๐๐๐ ๐๐ฎ๐ฌ๐ญ๐๐ข๐ง๐๐๐ข๐ฅ๐ข๐ญ๐ฒ ๐๐๐ฉ๐จ๐ซ๐ญ โ ๐ฅ๐ข๐ง๐ค ๐ข๐ง ๐๐จ๐ฆ๐ฆ๐๐ง๐ญ๐ฌ ๐ฅ
ย
SGDPharma BusinessValues Ethics Whistleblowing InformationSecurity